APA

Kiss L. S., Szamosi T., Molnar T., Miheller P., Lakatos L., Vincze A., Palatka K., Barta Z., Gasztonyi B., Salamon A., Horvath G., Tóth G. T., Farkas K., Banai J., Tulassay Z., Nagy F., Szenes M., Veres G., Lovasz B. D., Vegh Z., Golovics P. A., Szathmari M., Papp M. & Lakatos P. L. (20120315). Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease. : Alimentary pharmacology & therapeutics.

Chicago

Kiss L S, Szamosi T, Molnar T, Miheller P, Lakatos L, Vincze A, Palatka K, Barta Z, Gasztonyi B, Salamon A, Horvath G, Tóth G T, Farkas K, Banai J, Tulassay Z, Nagy F, Szenes M, Veres G, Lovasz B D, Vegh Z, Golovics P A, Szathmari M, Papp M and Lakatos P L. 20120315. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease. : Alimentary pharmacology & therapeutics.

Harvard

Kiss L. S., Szamosi T., Molnar T., Miheller P., Lakatos L., Vincze A., Palatka K., Barta Z., Gasztonyi B., Salamon A., Horvath G., Tóth G. T., Farkas K., Banai J., Tulassay Z., Nagy F., Szenes M., Veres G., Lovasz B. D., Vegh Z., Golovics P. A., Szathmari M., Papp M. and Lakatos P. L. (20120315). Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease. : Alimentary pharmacology & therapeutics.

MLA

Kiss L S, Szamosi T, Molnar T, Miheller P, Lakatos L, Vincze A, Palatka K, Barta Z, Gasztonyi B, Salamon A, Horvath G, Tóth G T, Farkas K, Banai J, Tulassay Z, Nagy F, Szenes M, Veres G, Lovasz B D, Vegh Z, Golovics P A, Szathmari M, Papp M and Lakatos P L. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease. : Alimentary pharmacology & therapeutics. 20120315.